One of the world’s leading developers of implantable neurostimulation devices selects clinivation WorldView® as their enterprise solution for on-demand global regulatory intelligence.
Natick, MA, October 14, 2008 – clinivation, Inc. announced today that Advanced Bionics has selected the clinivation WorldView® enterprise solution for On-Demand Global Regulatory Intelligence.
“Advanced Bionics is an innovative global leader in developing bionic technologies for people with hearing loss, and we are pleased that they have chosen clinivation WorldView® for comprehensive, authoritative, and up-to-date global regulatory intelligence,” said Richard Morroney, R.A.C., C.Q.A., clinivation’s Vice President of Quality and Regulatory Solutions.
About clinivation WorldView® On-Demand Global Regulatory Intelligence
Clinivation WorldView® is the medical device and diagnostic industry’s most comprehensive, authoritative, and up-to-date enterprise solution for On-Demand Global Regulatory Intelligence. Providing clear, step-by-step market clearance regulations, processes, and guidance for >99% of the world markets, only clinivation WorldView® delivers tried-and-true intelligence from certified, practicing professionals with real-world experience.
About Advanced Bionics
Headquartered in Sylmar, California, Advanced Bionics is a global leader in the development of implantable, high-technology neurostimulation devices. The company’s bionic technologies include new treatments for deafness and chronic pain. Advanced Bionics is the only American company that develops cochlear implant technology.
Advanced Bionics supports physicians, clinicians, and patients through scientific research, technology development, education and more and seeks to improve lives by developing, manufacturing, marketing, and supporting high-quality, state-of-the-art hearing technology for those with severe to profound hearing loss.
For more information, please visit www.advancedbionics.com.